A detailed history of Bank Of Nova Scotia transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bank Of Nova Scotia holds 180,259 shares of EW stock, worth $12.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
180,259
Previous 176,848 1.93%
Holding current value
$12.2 Million
Previous $16.3 Million 27.18%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $203,636 - $319,883
3,411 Added 1.93%
180,259 $11.9 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $63.7 Million - $71.3 Million
-755,915 Reduced 81.04%
176,848 $16.3 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $41.3 Million - $54.4 Million
569,144 Added 156.52%
932,763 $89.1 Million
Q4 2023

Feb 12, 2024

SELL
$61.71 - $77.76 $21.5 Million - $27.1 Million
-348,691 Reduced 48.95%
363,619 $27.7 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $25.3 Million - $34 Million
364,563 Added 104.84%
712,310 $49.3 Million
Q2 2023

Aug 03, 2023

SELL
$81.41 - $94.33 $4.72 Million - $5.47 Million
-58,003 Reduced 14.3%
347,747 $32.8 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $36.9 Million - $41.9 Million
-496,242 Reduced 55.02%
405,750 $33.6 Million
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $33.6 Million - $43 Million
492,193 Added 120.11%
901,992 $67.3 Million
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $419,922 - $546,964
5,098 Added 1.26%
409,799 $33.8 Million
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $2.34 Million - $3.47 Million
27,090 Added 7.17%
404,701 $38.5 Million
Q2 2022

Aug 08, 2022

SELL
$86.5 - $128.27 $50.3 Billion - $74.6 Billion
-581,712,108 Reduced 99.94%
377,611 $36 Million
Q2 2022

Aug 05, 2022

BUY
$86.5 - $128.27 $50.3 Billion - $74.6 Billion
581,671,529 Added 139092.64%
582,089,719 $27.4 Billion
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $64.4 Million - $81.1 Million
-631,991 Reduced 60.18%
418,190 $49.2 Million
Q4 2021

Feb 11, 2022

BUY
$106.37 - $130.68 $44.5 Million - $54.7 Million
418,306 Added 66.2%
1,050,181 $136 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $5.96 Million - $7.11 Million
-57,892 Reduced 8.39%
631,875 $71.5 Million
Q2 2021

Aug 12, 2021

BUY
$83.84 - $104.76 $57.8 Million - $72.3 Million
689,767 New
689,767 $71.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.